United States · Funded startup

Who invested in Attivare Therapeutics

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 11 months ago

Funding summaryUpdated 26 Oct 2026

$6.6Mraised across 1 round since 2025, from 1 source

Latest round
Grant, $6.6MDec 2025
Investors
3
See who backed them

The rounds

  1. Dec 2025

Founders and team

From the SEC filings it signed: 2 on the team.

  • Edward DohertyExecutive Officeri
  • Joaquim TriasExecutive Officer, Directori

On the board, as filediJessica McDonoughZeshan Muhammedi

Everyone who backed them

Bossa InvestVC firm1round
Ulu VenturesVC firm1round
AAF Management Ltd.VC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Attivare Therapeutics

Who invested in Attivare Therapeutics?

Attivare Therapeutics's investors include Bossa Invest, Ulu Ventures and AAF Management Ltd..

How much has Attivare Therapeutics raised?

Attivare Therapeutics has raised $6.6M across 1 round since 2025.

When did Attivare Therapeutics last raise?

Attivare Therapeutics's most recent round was a Grant of $6.6M in Dec 2025.

What was Attivare Therapeutics's biggest round?

Its most recent round, $6.6M in Dec 2025, is also its largest on record.

Who backed Attivare Therapeutics first?

Attivare Therapeutics's first round on record, in Dec 2025, was backed by Bossa Invest, Ulu Ventures and AAF Management Ltd..

What stage is Attivare Therapeutics at?

Attivare Therapeutics's latest named round is a Grant, in Dec 2025.

Where is Attivare Therapeutics based?

Attivare Therapeutics is based in the United States.

Companies like Attivare Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.